Formoterol (Foradilâ) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma
| dc.contributor.author | Mitchell, C. | en |
| dc.contributor.author | Jenkins, C. | en |
| dc.contributor.author | Scicchitano, Raffaele | en |
| dc.contributor.author | Rubinfeld, Abraham R. | en |
| dc.contributor.author | Kottakis, J. | en |
| dc.date.issued | 2003 | en |
| dc.identifier.citation | Pulmonary Pharmacology and Therapeutics. 16:299-306 | en |
| dc.identifier.issn | 1094-5539 | en |
| dc.identifier.uri | http://hdl.handle.net/2440/9757 | |
| dc.language.iso | en | en |
| dc.publisher | Academic Press Ltd | en |
| dc.title | Formoterol (Foradilâ) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma | en |
| dc.title.alternative | Formoterol (Foradila) and medium-high doses of inhaled corticosteroids are more effective than high doses of corticosteroids in moderate-to-severe asthma | en |
| dc.type | Journal article | en |